Patients with mental disorders are often found to be suffering from immense physical and emotional pains, which affects normal activities of daily life, and places a heavy burden on the patients and their families.

• We have worked with physicians to establish a psychological counseling platform and share mental health information, etc. Our efforts have helped to treat some patients with mild mental disorders or improve their conditions in a timely manner.
• We have also developed a number of unique drugs against common mental disorders such as sleep disorders, depression, and schizophrenia. By combining Traditional Chinese Medicine with modern medicine, and constantly consolidating our experiences, we have developed the Shuganjieyu capsule, an evidence-based medicine which has been scientifically verified. Compared with traditional antidepressants, the Shuganjieyu capsule enjoys a lower rate of adverse reactions, better safety, and greater efficacy without statistically significant differences. Furthermore, compliance in patients with moderate to mild depression is particularly high. Kanghong Pharmaceutical has also launched several chemical drugs with multiple patented technologies, such as aripiprazole orally-disintegrating tablets, venlafaxine hydrochloride sustained-release tablets, and mosapride tablets, all of which are leading brands in their respective therapeutic fields.